Last Updated on January 4, 2024 by The Health Master
New Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of hard gelatin capsule containing Atorvastatin Calcium plus Clopidogrel Bisulphate plus Aspirin manufactured by Windlas Biotech and marketed by Torrent Pharmaceuticals.
The retail price of each hard gelatin capsule containing Atorvastatin Calcium plus Clopidogrel Bisulphate plus Aspirin has been set at Rs. 12.92 per capsule, excluding GST.
Atorvastatin Calcium plus Clopidogrel Bisulphate plus Aspirin is a combination drug of blood-thinning agents and cholesterol-lowering agents, primarily taken for the prevention of heart attack and stroke.
Atorvastatin is an HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease, including myocardial infarction and stroke.
Clopidogrel Bisulfate is a thienopyridine with antiplatelet activity. Clopidogrel bisulfate irreversibly alters the platelet receptor for adenosine diphosphate (ADP), thereby blocking the binding of ADP to its receptor, inhibiting ADP-mediated activation of the glycoprotein complex GPIIb/IIIa, and inhibiting fibrinogen binding to platelets and platelet adhesion and aggregation.
Aspirin is a salicylate used to treat pain, fever, inflammation, migraines, and reducing the risk of major adverse cardiovascular events.
At a recent Multidisciplinary Committee of Experts meeting, the Committee noted that, as per the provisions of DPCO 2013, the retail price of each hard gelatin capsule contains Atorvastatin Calcium IP eq. Atorvastatin 40 mg (as coloured pellets) + Clopidogrel Bisulphate IP eq. Clopidogrel 75 mg (as two brown coloured film coated tablets each containing 37.5 mg of Clopidogrel tablet IP) + Aspirin IP 75 mg (as enteric coated white-coloured peIlets) for Windlas Biotech Ltd. (manufacturer) and Torrent Pharmaceuticals Ltd. (marketer) is required to be calculated based on the market data for the month of March 2021.
The Committee further noted that data for the formulation was not available in the Pharmatrac database for the month of March 2021. However, the data for the formulation started appearing in April 2021.
The Committee also noted that the applicant company has claimed retail price of Rs. 18.00 per capsule excluding GST.
The Committee deliberated upon the matter in detail and decided to fix the retail price of the subject formulation by calculating as per the formula provided in DPCO 2013 for calculating the retail price of new drugs based on April 2021 data as available in the Pharmatrac database.
Latest on National Pharmaceutical Pricing Authority (NPPA)
Latest notifications – DPCO / NPPA
Latest Notifications: EC Act (Essential Commodities Act)
FAQs – On DPCO: Drugs (Prices Control) Order, 2013
NDPS: 9 arrested for selling drugs
Hindustan Syringes and Medical Devices allowed to restart production
Action sought against Hetero Pharma: HRF
KSRPA asks Govt to amend Rule 123 of D&C Rules w.r.t. Schedule K
USFDA approves Eye Drops that could replace reading glasses
Drug recall: Lupin recalls 4,113 cartons of oral contraceptive
Inquiry needed into unfair trade practice of discount pricing by Medical…
Increase in Pharmacy colleges to meet rising demand of Medical Stores
Procedure for registration of Medical Devices: CDSCO
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
